The findings from our prior investigation align with the results of the current study, which showed that ASX has the ability to enhance BCL2 expression and reduce BAX expression in the GCs of PCOS patients (Jabarpour et al., 2024). This evidence concerns the gene BCL2 and polycystic ovary syndrome.